HLA – B5 (B*51/52)

This Test is a specialized genetic test that identifies specific human leukocyte antigen (HLA) types, particularly HLA-B51 and HLA-B52. These markers are part of the immune system and play a role in how the body recognizes and responds to foreign substances.

HLA-B51 is strongly associated with Behçet’s disease, a rare autoimmune disorder that causes inflammation in blood vessels, leading to symptoms such as mouth ulcers, genital sores, skin lesions, and eye inflammation. HLA-B52 may also be linked to certain inflammatory and autoimmune conditions.

The purpose of this test is to:

• Detect HLA-B51 and HLA-B52 genetic markers
• Assess genetic susceptibility to autoimmune diseases
• Support diagnosis of Behçet’s disease
• Assist in clinical evaluation of immune-related conditions

HLA – B5 (B*51/52) Test

The HLA-B5 (B51/B52) test is a genetic test used to identify whether a person carries the HLA-B51 or HLA-B52 allele group. HLA (Human Leukocyte Antigen) proteins help the immune system distinguish the body’s own cells from foreign substances.

HLA-B51 is particularly associated with an increased susceptibility to Behçet’s disease, an inflammatory condition that can cause recurrent oral and genital ulcers, eye inflammation, and other symptoms. However, having HLA-B51 does not mean that a person has or will develop Behçet’s disease.

HLA-B52 may also be associated with susceptibility to certain immune-mediated conditions in specific populations. The result is therefore considered a genetic susceptibility marker rather than a diagnostic test. It should be interpreted along with symptoms, clinical examination, and other investigations.

HLA – B5 (B*51/52) Test Recommended for Individuals:

• Individuals being evaluated for suspected Behçet’s disease
• Patients with recurrent oral or genital ulcers and other compatible symptoms
• People with unexplained inflammatory or immune-related symptoms
• Individuals undergoing HLA typing as recommended by a specialist
• Patients whose healthcare provider wants to assess HLA-B51/B*52 status
• Individuals undergoing evaluation of certain HLA-associated diseases

FAQs

1. What does the HLA-B5 (B51/B52) test detect?
It identifies whether specific HLA-B51 or HLA-B52 genetic markers are present. These markers are associated with susceptibility to certain immune-mediated conditions.

2. Does a positive HLA-B51 result mean I have Behçet’s disease?
No. HLA-B51 is a susceptibility marker, not a diagnostic test. Many people who carry HLA-B51 never develop Behçet’s disease, and the diagnosis is based primarily on clinical signs and symptoms.

3. Why might my doctor recommend HLA-B5 testing?
The test may be recommended when a healthcare provider is evaluating Behçet’s disease or another HLA-associated condition. The result can provide supporting genetic information but must be interpreted alongside the patient’s clinical findings.